I Holland Launches New Packaging Solution to Eliminate Potential Tool Tip Damage - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

I Holland Launches New Packaging Solution to Eliminate Potential Tool Tip Damage

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 8

I Holland, a specialist manufacturer of tablet tooling for the pharmaceutical and nutraceutical industries, has released a new packaging solution to ensure its products arrive in perfect condition. PrimePac tubes (patent pending), part of the company’s new portfolio of packaging, have been specifically designed with a safety zone to hold tablet punches in position to stop damage to the tip face.

Michael Oxford, R&D engineer, I Holland, notes that one of the most important and fundamental problems when transporting tablet tooling is ensuring that the punch tip face is undamaged. “Any damage to the very delicate land area will result in reduction of punch life when the punch is placed under stress in operation,” he explains.

“Although our previous packaging tubes have served us well, we felt that re-designing them to incorporate an innovative safety zone ensures the quality of the product, knowing that it will arrive with the customer in the same quality condition that it left the factory,” Oxford continues. “By designing the PrimePac range, we can maintain our customer service and ensure the end user receives the best quality product available, something very important to I Holland.”

Current methods of packaging protection commonly used by punch and die manufacturers include foam inserts or cardboard inner tubes, which do not have the protective power of the new designed PrimePac solution. The new packaging tubes will be rolled out in the coming months.

Source: I Holland

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here